Novel Strategies in Hematopoietic Stem Cell Transplantation
Open Access
- 20 December 2016
- journal article
- Published by Peertechz Publications Private Limited
- Vol. 1 (1), 005-006
- https://doi.org/10.17352/abmr.000002
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myelomaTransfusion, 2014
- Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumorsAnti-Cancer Drugs, 2014
- The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than PlerixaforLeukemia, 2013
- Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an updateBlood Cancer Journal, 2011
- Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilizationBlood, 2009
- Endochondral ossification is required for haematopoietic stem-cell niche formationNature, 2008
- Space‐time considerations for hematopoietic stem cell transplantationEuropean Journal of Immunology, 2008
- Hematopoietic Stem and Progenitor Cells: Clinical and Preclinical Regeneration of the Hematolymphoid SystemAnnual Review of Medicine, 2005
- Nonmalignant late effects after allogeneic stem cell transplantationBlood, 2003
- Acute and delayed toxicities of total body irradiationEndocrine, 1983